StockData
BeOne Medicines Ltd. logo

BeOne Medicines Ltd.

ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/302252% above fair value
$361.27−9.06 (-2.45%)

Close on Nov 2, 2026Market cap $41.08BP/E 64.6Yield –

BeOne Medicines Non-GAAP Adjusted Basic Earnings (Loss) per ADS by Year

Non-GAAP Adjusted Basic Earnings (Loss) per ADS ($/ADS) ($)

QuarterlyAnnual

BeOne Medicines Non-GAAP Adjusted Basic Earnings (Loss) per ADS: $8.41 in FY2025, down 1,717.3% from a year earlier.

Latest, FY2025
8.41
Period ended Dec 31, 2025
Change on a year earlier
-1,717.3%
-0.52 in FY2024
History
2 years
Since FY2024
Sources
1
Form 8-K (filed 2026-02-26)

Where the FY2025 figure comes from

“|| Adjusted earnings (loss) per ADS - basic | $ | 2.03 | $ | 0.15 | $ | 8.41 | $ | (0.52)”

Source: Form 8-K (filed 2026-02-26) ↗

Reported in Form 8-K EX-99.1 Non-GAAP Reconciliation Tables.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedNon-GAAP Adjusted Basic Earnings (Loss) per ADS ($/ADS) ($)Year on yearSource
FY2025Dec 31, 20258.41-1,717.3%Form 8-K (filed 2026-02-26) ↗
FY2024Dec 31, 2024-0.52–Form 8-K (filed 2026-02-26) ↗

Cite this data

StockData. (2026). BeOne Medicines Non-GAAP Adjusted Basic Earnings (Loss) per ADS ($), annual FY2024–FY2025 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/adj-eps-ads-basic

See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.